LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. LDL SUBFRACTIONAL ANALYSIS: A LABORATORY DIAGNOSTIC ASSAY IN PATIENTS WITH CAROTID AND CORONARY ATHEROSCLEROSIS

被引:0
|
作者
Gavrilova, N. [1 ]
Metelskaya, V. [2 ]
Ozerova, I. [2 ]
Yarovaya, E. [3 ]
Boytsov, S. [1 ]
机构
[1] Natl Res Ctr Prevent Med, Cardiol, Moscow, Russia
[2] Natl Res Ctr Prevent Med, Biochem, Moscow, Russia
[3] Natl Res Ctr Prevent Med, Biostat, Moscow, Russia
关键词
D O I
10.1016/j.atherosclerosis.2016.07.571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EAS16-0095
引用
收藏
页码:E101 / E101
页数:1
相关论文
共 37 条
  • [1] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. ADIPONECTIN AS A BLOCKER OF OXIDIZED LDL
    Kakino, A.
    Fujita, Y.
    Sawamura, T.
    ATHEROSCLEROSIS, 2016, 252 : E103 - E103
  • [2] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. MULTIPLE MODIFICATION OF LDL CIRCULATING IN BLOOD OF ATHEROSCLEROTIC PATIENTS
    Orekhov, A.
    Sobenin, I.
    Melnichenko, A.
    ATHEROSCLEROSIS, 2016, 252 : E102 - E102
  • [3] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. THERMAL STABILITY OF HUMAN PLASMA LDL(-): A PARADOXICAL BEHAVIOR OF LDL AGGREGATION
    Rull, A.
    Jayaraman, S.
    Rivas, A.
    Perez Cuellar, M.
    Ordonez Llanos, J.
    Sanchez Quesada, J. L.
    Gursky, O.
    ATHEROSCLEROSIS, 2016, 252 : E101 - E101
  • [4] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. SUBFRACTIONAL DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS: A NEW MARKER FOR DETECTION OF INDIVIDUAL CARDIOVASCULAR RISK
    Metelskaya, V.
    Ozerova, I.
    Gavrilova, N.
    Yarovaya, E.
    Boytsov, S.
    ATHEROSCLEROSIS, 2016, 252 : E104 - E104
  • [5] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. COMPARABILITY STUDY OF CANDIDATE REFERENCE METHODS FOR LDL-P MEASUREMENTS
    Foraison, N. Clouet
    Vaslin-Reimann, S.
    Cobbaert, C.
    Gillery, P.
    Delatour, V.
    ATHEROSCLEROSIS, 2016, 252 : E102 - E102
  • [6] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. THE DETERMINATION OF APOLIPOPROTEIN B BY CALCULATION AND BY MEASUREMENT ON SET OF DYSLIPIDEMIC PATIENTS
    Cibickova, L.
    Gasko, R.
    Vaverkova, H.
    Karasek, D.
    ATHEROSCLEROSIS, 2016, 252 : E102 - E103
  • [7] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. THE ROLE OF ANGPTL3 IN HUMAN LIPOPROTEIN METABOLISM
    Tikka, A.
    Metso, J.
    Jauhiainen, M.
    ATHEROSCLEROSIS, 2016, 252 : E99 - E99
  • [8] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. ASSOCIATION OF THE POSTPRANDIAL CHYLOMICRON TRIGLYCERIDE/ APOB INDEX AND CARDIOVASCULAR EVENTS
    Scharnagl, H.
    Werner, C.
    Stojakovic, T.
    Maerz, W.
    Laufs, U.
    ATHEROSCLEROSIS, 2016, 252 : E99 - E99
  • [9] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. POLOXAMERS INHIBIT ASSOCIATION OF MULTIPLY MODIFIED LDL, BUT DO NOT REDUCE THEIR ATHEROGENIC POTENTIAL
    Melnichenko, A.
    Elizova, N.
    Orekhov, A.
    ATHEROSCLEROSIS, 2016, 252 : E102 - E102
  • [10] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. SYSTEMATIC ASSAY OF LIPOPROTEIN LIPASE ACTIVITY AND MASS IN COHORT OF PATIENTS WITH HISTORY OF TYPE V HYPERLIPIDEMIA
    Marmontel, O.
    di Filippo, M.
    Nony, S.
    Marcais, C.
    Caussy, C.
    Charriere, S.
    Sassolas, A.
    Moulin, P.
    ATHEROSCLEROSIS, 2016, 252 : E99 - E100